Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Jul 27, 2026 · Filed Jul 29, 2026

On Jul 27, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at US$34.95 for US$6.99M under a trading plan, leaving 1,613,063 shares. Filed Jul 29, 2026 (Form 4).

Sold: 200,000 shares
Price: US$34.95
Value: US$6.99M
Holding after: 1,613,063 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jul 27, 2026	Common Shares	Option exercise	200,000	US$3.85	1,813,063	Direct
Jul 27, 2026	Common Shares	Sale	200,000	US$34.95	1,613,063	Direct

Source

View original at SEC

Related